SV7 Impact Medicine Fund LP

Insider Reports History

Entity
Company
Location
71 Kingsway, London, United Kingdom
Signature
/s/ Kathleen R. Henry, pursuant to Power of Attorney for SV7 Impact Medicine Fund LP
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by SV7 Impact Medicine Fund LP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 1.61M $1.34M $0.83 Oct 26, 2021 Direct
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 1.61M $1.34M $0.83 Oct 26, 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Oct 26, 2021 Direct
Xilio Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Oct 26, 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Series C Convertible Preferred Stock 0 Oct 26, 2021 Direct
Xilio Therapeutics, Inc. 10%+ Owner Series C Convertible Preferred Stock 0 Oct 26, 2021 Indirect

Insider Reports Filed by SV7 Impact Medicine Fund LP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XLO Xilio Therapeutics, Inc. Oct 26, 2021 10 $10M 4/A Nov 3, 2021 10%+ Owner
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 10%+ Owner